細胞遺傳學的全球市場:市場規模，佔有率，預測，趨勢分析:報價環，各技術，各用途，各終端用戶，各地區-2031年為止的預測

預計到 2023 年全球細胞遺傳學市場價值將達到 26 億美元。預計市場規模將從 2024 年的 29 億美元成長到 2031 年的 55 億美元，預測期內（2024-2031 年）的複合年增長率為 9.6%。

全球細胞遺傳學市場的成長得益於對預防性醫療保健措施的日益關注、基因異常的流行、人口老齡化的增加和各種慢性疾病的增加、降低醫療保健成本的日益增長的需求以及對監測和臨床診斷的日益關注。然而，對新興診斷技術缺乏認識、不利的報銷情況以及設備的技術限制和複雜性阻礙了市場的成長。

此外，由於預測性和預後基因檢測的增加，中國、印度、韓國和東南亞對標靶治療的日益關注預計將為市場成長創造機會。然而，對基因數據的安全性和隱私性的擔憂、基因組技術的商業化和擴展以及遺傳學缺乏標準化方法是全球細胞遺傳學市場面臨的主要課題。

根據供應情況，預計預測期內消耗品部門的複合年增長率高達 10.2%。該領域的高複合年增長率可歸因於常規細胞遺傳學測試和研究中對消耗品的高需求、由於遺傳疾病患病率上升而導致的診斷應用的增加、消耗品的技術進步以及消耗品的重複使用。

陣列比較基因組雜交和噴墨微陣列製造等技術進步、CGH 有助於早期疾病診斷並簡化診斷程序、探針創建演算法的最佳化、克隆庫開發以及診斷和治療目標的識別應用正在促進該領域最大佔有率的增長。

按應用劃分，臨床領域預計在 2024 年佔據最大的市場佔有率，達到 82.6%。該領域市場佔有率的擴大可歸因於遺傳疾病和癌症患病率的上升、診斷技術的進步、患者意識的增強和政府對早期診斷的舉措、個性化醫療的日益普及以及廣泛的診斷應用。

按本報告提供全球細胞遺傳學市場相關調查，提供市場現狀，以及報價環，各技術，各用途，各終端用戶，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 市場定義和範圍

第2章 調查手法

第3章 摘要整理

第4章 市場洞察

• 概要
• 市場成長的影響因素
• 主要趨勢
• 法規分析
• 波特的五力分析

第5章 細胞遺傳學市場評估，報價環

• 概要
• 消耗品
• 設備
• 軟體
• 服務

第6章 細胞遺傳學市場評估，各技術

• 概要
• 比較基因雜合反應
• 螢光原位雜合反應(FISH)
• 染色體組型分析
• 其他

第7章 細胞遺傳學市場評估，各用途

• 概要
• 臨床
• 研究

第8章 細胞遺傳學市場評估，各終端用戶

• 概要
• 臨床·診斷研究室
• 製藥公司·生物科技企業
• 研究·學術機構
• 其他

第9章 細胞遺傳學市場評估，各地區

• 概要
• 北美
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 法國
  • 義大利
  • 英國
  • 西班牙
  • 其他
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他
• 南美
• 中東·非洲

第10章 競爭分析

• 概要
• 主要的成長策略
• 競爭基準
• 競爭儀表板
• 主要加入企業市場佔有率/排行榜分析，2023年

第11章 企業簡介(產業概要，財務概要，產品系列，策略開發，SWOT分析)

• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Agilent Technologies, Inc.
• Revvity, Inc.
• Applied Spectral Imaging
• Bio-Rad Laboratories, Inc.
• Sysmex Corporation
• Illumina, Inc.
• F. Hoffman-La-Roche Ltd
• Leica Biosystems
• Quest Diagnostics Incorporated

第12章 附錄

Cytogenetics Market Size, Share, Forecast, & Trends Analysis by Offering (Consumables, Instruments, Software, Services), Technique (Comparative Genomic Hybridization, FISH, Karyotyping), Application (Clinical, Research), End User Global Forecast to 2031

The Cytogenetics Market was valued at $2.6 billion in 2023. This market is expected to reach $5.5 billion by 2031 from an estimated $2.9 billion in 2024, at a CAGR of 9.6% during the forecast period of 2024-2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the global cytogenetics market is driven by increasing focus on preventive healthcare measures, prevalence of genetic abnormalities, increasing aging population and subsequent increase in various chronic diseases, growing need to reduce mounting healthcare cost and increasing focus on research and clinical diagnosis. However, lack of awareness about emerging diagnostic technologies, unfavorable reimbursement scenarios and technical limitations and complexities of the equipment are restraining the market's growth.

Furthermore, emerging economies: China, India, South Korea, and Southeast Asia, increasing focus on target-based therapies and increase in predictive and presymptomatic genetic testing are expected to generate market growth opportunities. However, concerns regarding the security & privacy of genetic data, commercialization and scaling of genomic technologies and lack of standardized approaches in genetics are major challenges in the global cytogenetics market.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over years (2021-2024). The key players operating in the cytogenetics market are Thermo Fisher Scientific, Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies, Inc. (U.S.), Revvity, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Applied Spectral Imaging, Inc. (U.S.), Quest Diagnostics Incorporated (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (U.S.), Illumina, Inc. (U.S.) and Sysmex Corporation (Japan)

Among all the offerings studied in this report, the consumables segment is projected to register the highest CAGR of 10.2% during the forecast period. The high CAGR of the segment is attributed to the high demand of consumables for routine cytogenetic testing and research, increased diagnostic applications due to growing prevalence of genetic disorders, technological advancements in consumables and recurring use of consumables.

Among all the techniques studies in this report, in 2024, comparative genomic hybridization accounted for the larger share of 56.7%. technological advancements such as array comparative genomic hybridization and inkjet microarray manufacturing, CGH helps in early disease diagnosis and simplifies diagnostic procedures, optimize probe creation algorithms, clone library development, and its application in identifying diagnostic and therapeutic targets. These factors are contributing to the growth of largest share of the segment.

Among all the applications studied in this report, in 2024, clinical applications segment accounted for the largest share of 82.6%. The segment's larger share can be attributed to the increasing prevalence of genetic disorders and cancers, advancements in diagnostic technologies, rising patient awareness and government initiatives for early diagnosis, growing adoption of personalized medicine, and wide diagnostic applications.

An in-depth analysis of the geographical scenario of the global cytogenetics market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Asia Pacific is projected to register the highest CAGR of 10.2% during the forecast period. The fastest growth of the market is due to the rising pharmaceutical R&D spending, growth in the biotechnology industry, the increasing prevalence of chronic and infectious diseases, and the rising number of diagnostic laboratories are further expected to drive the cytogenetics market in the region.

Scope of the Report:

Cytogenetics Market Assessment-by Offering

• Consumables
  • Kits & Reagents
• Testing Kits
• Probes
• Other Reagents
  • Other Consumables
• Instruments
• Software
• Services

(Note 1: other reagents include sample preparation and assays)

(Note 2: other consumables include columns, strainers, tips, holders, adapters, caps, digestion vessels, and cartridges.)

Cytogenetics Market Assessment-by Technique

• Comparative Genomic Hybridization
• Fluorescence In Situ Hybridization (FISH)
• Karyotyping
• Other Techniques

(Note: Other Techniques include sister chromatid exchange (SCE))

Cytogenetics Market Assessment-by Application

• Clinical Applications
  • Prenatal & Genetic Testing
  • Oncology
  • Other Clinical Applications
• Research Applications

(Note: Other clinical applications include hematology, predictive and presymptomatic testing, and preimplantation testing)

Cytogenetics Market Assessment-by End User

• Clinical & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Research & Academic Institutes
• Other End Users

(Note: Other end users include agriculture companies, food & beverage companies, and forensics)

Cytogenetics Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • U.K.
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of Asia-Pacific (RoAPAC)
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Market Definition & Scope

• 1.1. Market Definition
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection and Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews With Key Opinion Leaders From The Industry
• 2.3. Market Sizing and Forecast
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for The Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Factors Affecting Market Growth
  • 4.2.1. Impact Analysis of Market Dynamics
    • 4.2.1.1. Prevalence of Genetic Abnormalities and Genetic Disorders
    • 4.2.1.2. Concerns Regarding the Security & Privacy of Genetic Data
  • 4.2.2. Macro Indicators
• 4.3. Key Trends
  • 4.3.1. Use of Chromosome Conformation Capture (3C) In Cytogenetics
  • 4.3.2. Transition From Fluorescence In Situ Hybridization (FISH) To Array Based Techniques
• 4.4. Regulatory Analysis
• 4.5. Porter's Five Forces Analysis

5. Cytogenetics Market Assessment-By Offering

• 5.1. Overview
• 5.2. Consumbles
  • 5.2.1. Kits & Reagents
    • 5.2.1.1. Testing Kits
    • 5.2.1.2. Probes
    • 5.2.1.3. Other Reagents
  • 5.2.2. Other Consumables
• 5.3. Instruments
• 5.4. Software
• 5.5. Services

6. Cytogenetics Market Assessment-By Technique

• 6.1. Overview
• 6.2. Comparative Genomic Hybridization
• 6.3. Fluorescence In Situ Hybridization (FISH)
• 6.4. Karyotyping
• 6.5. Other Techniques

7. Cytogenetics Market Assessment-By Application

• 7.1. Overview
• 7.2. Clinical Applications
  • 7.2.1. Prenatal & Genetic Testing
  • 7.2.2. Oncology
  • 7.2.3. Other Clinical Applications
• 7.3. Research Applications

8. Cytogenetics Market Assessment-By End User

• 8.1. Overview
• 8.2. Clinical & Diagnostic Laboratories
• 8.3. Pharmaceutical & Biotechnology Companies
• 8.4. Research & Academic Institutes
• 8.5. Other End Users

9. Cytogenetics Market Assessment-By Geography

• 9.1. Overview
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. Italy
  • 9.3.4. U.K.
  • 9.3.5. Spain
  • 9.3.6. Rest of Europe (Roe)
• 9.4. Asia-Pacific
  • 9.4.1. China
  • 9.4.2. Japan
  • 9.4.3. India
  • 9.4.4. Rest of Asia-Pacific (Roapac)
• 9.5. Latin America
• 9.6. Middle East & Africa

10. Competition Analysis

• 10.1. Overview
• 10.2. Key Growth Strategies
• 10.3. Competitive Benchmarking
• 10.4. Competitive Dashboard
  • 10.4.1. Industry Leaders
  • 10.4.2. Market Differentiators
  • 10.4.3. Vanguards
  • 10.4.4. Emerging Companies
• 10.5. Market Share/Ranking Analysis, By The Key Players, 2023

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and Swot Analysis*)

• 11.1. Thermo Fisher Scientific Inc. (U.S.)
• 11.2. Abbott Laboratories (U.S.)
• 11.3. Agilent Technologies, Inc. (U.S.)
• 11.4. Revvity, Inc. (U.S.)
• 11.5. Applied Spectral Imaging (U.S.)
• 11.6. Bio-Rad Laboratories, Inc. (U.S.)
• 11.7. Sysmex Corporation (Japan)
• 11.8. Illumina, Inc. (U.S.)
• 11.9. F. Hoffman-La-Roche Ltd (Switzerland)
• 11.10. Leica Biosystems (subsidiary of Danaher Corporation) (U.S.)
• 11.11. Quest Diagnostics Incorporated (U.S.)

(Note: Swot Analysis* Will Be Provided of The Top 5 Companies)

12. Appendix

• 12.1. Available Customization
• 12.2. Related Reports

LIST OF TABLES

• Table 1. Healthcare Spending, By Country, 2022 (USD/Per Capita)
• Table 2. Number of New Cancer Cases, By Type (2020 Vs. 2030)
• Table 3. Authorities Regulating In Vitro Diagnostic Products, By Country/Region
• Table 4. Canada: Medical Device Approval Procedures, By Class
• Table 5. China: Medical Device Approval Procedures, By Class
• Table 6. Rest of Apac: Authorities Regulating Medical Devices, By Country
• Table 7. South Africa: Medical Device Approval Procedures, By Class
• Table 8. Global Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 9. Global Cytogenetic Consumables Market, By Type, 2022-2031 (USD Million)
• Table 10. Global Cytogenetic Consumables Market, By Country/Region, 2022-2031 (USD Million)
• Table 11. Global Cytogenetic Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 12. Global Cytogenetic Kits & Reagents Market, By Country/Region, 2022-2031 (USD Million)
• Table 13. Global Cytogenetic Testing Kits Market, By Country/Region, 2022-2031 (USD Million)
• Table 14. Global Cytogenetic Probes Market, By Country/Region, 2022-2031 (USD Million)
• Table 15. Global Cytogenetic Other Reagents Market, By Country/Region, 2022-2031 (USD Million)
• Table 16. Global Other Consumables Market, By Country/Region, 2022-2031 (USD Million)
• Table 17. Global Cytogenetic Instruments Market, By Country/Region, 2022-2031 (USD Million)
• Table 18. Global Cytogenetic Software Market, By Country/Region, 2022-2031 (USD Million)
• Table 19. Global Cytogenetic Services Market, By Country/Region, 2022-2031 (USD Million)
• Table 20. Global Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 21. Global Cytogenetic Instruments Market for Comparative Genomic Hybridization, By Country/Region, 2022-2031 (USD Million)
• Table 22. Global Cytogenetics Market for Fluorescence In Situ Hybridization, By Country/Region, 2022-2031 (USD Million)
• Table 23. Global Cytogenetic Karyotyping Market, By Country/Region, 2022-2031 (USD Million)
• Table 24. Global Other Cytogenetic Techniques Market, By Country/Region, 2022-2031 (USD Million)
• Table 25. Global Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 26. Global Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 27. Global Cytogenetics Market for Clinical Applications, By Country/ Region, 2022-2031 (USD Million)
• Table 28. Global Cytogenetics Market for Prenatal & Genetic Testing, By Country/ Region, 2022-2031 (USD Million)
• Table 29. Global Cytogenetics Market for Oncology, By Country/Region, 2022-2031 (USD Million)
• Table 30. Global Cytogenetics Market for Other Applications, By Country/Region, 2022-2031 (USD Million)
• Table 31. Global Cytogenetics Market for Research Applications, By Country/ Region, 2022-2031 (USD Million)
• Table 32. Global Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 33. Global Cytogenetics Market for Clinical & Diagnostic Laboratories, By Country/Region, 2022-2031 (USD Million)
• Table 34. Global Cytogenetics Market for Pharmaceutical & Biotechnology Companies, By Country/Region, 2022-2031 (USD Million)
• Table 35. Global Cytogenetics Market for Research & Academic Institutes, By Country/ Region, 2022-2031 (USD Million)
• Table 36. Global Cytogenetics Market for Other End Users, By Country/Region, 2022-2031 (USD Million)
• Table 37. Global Cytogenetics Market, By Country/Region, 2022-2031 (USD Million)
• Table 38. North America: Cytogenetics Market, By Country, 2022-2031 (USD Million)
• Table 39. North America: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 40. North America: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 41. North America: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 42. North America: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 43. North America: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 44. North America: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 45. North America: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 46. U.S.: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 47. U.S.: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 48. U.S.: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 49. U.S.: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 50. U.S.: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 51. U.S.: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 52. U.S.: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 53. Canada: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 54. Canada: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 55. Canada: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 56. Canada: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 57. Canada: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 58. Canada: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 59. Canada: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 60. Europe: Cytogenetics Market, By Country, 2022-2031 (USD Million)
• Table 61. Europe: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 62. Europe: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 63. Europe: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 64. Europe: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 65. Europe: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 66. Europe: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 67. Europe: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 68. Germany: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 69. Germany: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 70. Germany: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 71. Germany: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 72. Germany: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 73. Germany: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 74. Germany: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 75. France: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 76. France: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 77. France: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 78. France: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 79. France: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 80. France: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 81. France: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 82. Italy: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 83. Italy: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 84. Italy: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 85. Italy: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 86. Italy: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 87. Italy: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 88. Italy: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 89. U.K.: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 90. U.K.: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 91. U.K.: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 92. U.K.: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 93. U.K.: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 94. U.K.: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 95. U.K.: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 96. Spain: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 97. Spain: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 98. Spain: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 99. Spain: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 100. Spain: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 101. Spain: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 102. Spain: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 103. Rest of Europe: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 104. Rest of Europe: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 105. Rest of Europe: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 106. Rest of Europe: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 107. Rest of Europe: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 108. Rest of Europe: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 109. Rest of Europe: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 110. Asia Pacific: Cytogenetics Market, By Country, 2022-2031 (USD Million)
• Table 111. Asia Pacific: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 112. Asia Pacific: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 113. Asia Pacific: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 114. Asia Pacific: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 115. Asia Pacific: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 116. Asia Pacific: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 117. Asia Pacific: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 118. China: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 119. China: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 120. China: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 121. China: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 122. China: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 123. China: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 124. China: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 125. Japan: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 126. Japan: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 127. Japan: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 128. Japan: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 129. Japan: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 130. Japan: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 131. Japan: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 132. India: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 133. India: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 134. India: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 135. India: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 136. India: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 137. India: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 138. India: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 139. Rest of Asia Pacific: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 140. Rest of Asia Pacific: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 141. Rest of Asia Pacific: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 142. Rest of Asia Pacific: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 143. Rest of Asia Pacific: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 144. Rest of Asia Pacific: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 145. Rest of Asia Pacific: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 146. Latin America: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 147. Latin America: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 148. Latin America: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 149. Latin America: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 150. Latin America: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 151. Latin America: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 152. Latin America: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 153. Middle East & Africa: Cytogenetics Market, By Offering, 2022-2031 (USD Million)
• Table 154. Middle East & Africa: Cytogenetics Consumables Market, By Type, 2022-2031 (USD Million)
• Table 155. Middle East & Africa: Cytogenetics Kits & Reagents Market, By Type, 2022-2031 (USD Million)
• Table 156. Middle East & Africa: Cytogenetics Market, By Technique, 2022-2031 (USD Million)
• Table 157. Middle East & Africa: Cytogenetics Market, By Application, 2022-2031 (USD Million)
• Table 158. Middle East & Africa: Cytogenetics Market for Clinical Applications, By Type, 2022-2031 (USD Million)
• Table 159. Middle East & Africa: Cytogenetics Market, By End User, 2022-2031 (USD Million)
• Table 160. Recent Developments, By Company, 2021-2024

LIST OF FIGURES

• Figure 1. Research Process
• Figure 2. Secondary Sources Referenced for This Study
• Figure 3. Primary Research Techniques
• Figure 4. Key Executives Interviewed
• Figure 5. Breakdown of Primary Interviews (Supply Side & Demand Side)
• Figure 6. Market Sizing and Growth Forecast Approach
• Figure 7. Global Cytogenetics Market, By Offering, 2024 Vs. 2031 (USD Million)
• Figure 8. Global Cytogenetics Market, By Technique, 2024 Vs. 2031 (USD Million)
• Figure 9. Global Cytogenetics Market, By Application, 2024 Vs. 2031 (USD Million)
• Figure 10. Global Cytogenetics Market, By End User, 2024 Vs. 2031 (USD Million)
• Figure 11. Global Cytogenetics Market, By Geography, 2024 Vs. 2031 (USD Million)
• Figure 12. Impact Analysis of Market Dynamics
• Figure 13. Percentage of The Population Aged 65 Years Or Over, By Region, 2022 Vs. 2030 (%)
• Figure 14. Global Biopharmaceutical R&D Spending, 2012-2026 (USD Billion)
• Figure 15. India: Medical Device Regulatory Pathways
• Figure 16. Porter's Five Forces Analysis
• Figure 17. Global Cytogenetics Market, By Offering, 2024 Vs. 2031 (USD Million)
• Figure 18. Global Cytogenetics Consumables Market, By Type, 2024 Vs. 2031 (USD Million)
• Figure 19. Global Cytogenetics Kits & Reagents Market, By Type, 2024 Vs. 2031 (USD Million)
• Figure 20. Global Cytogenetics Market, By Technique, 2024 Vs. 2031 (USD Million)
• Figure 21. Global Cytogenetics Market, By Application, 2024 Vs. 2031 (USD Million)
• Figure 22. Global Cytogenetics Market for Clinical Applications, By Type, 2024 Vs. 2031 (USD Million)
• Figure 23. Global Cytogenetics Market, By End User, 2024 Vs. 2031 (USD Million)
• Figure 24. Global Cytogenetics Market, By Geography, 2024 Vs. 2031 (USD Million)
• Figure 25. North America: R&D Expenditures of Pharmaceutical Companies, 2019-2022 (USD Million)
• Figure 26. North America: Population Aged 65 Years Or Over, 2015-2021 (In Million)
• Figure 27. North America: Cytogenetics Market Snapshot
• Figure 28. Europe: Pharmaceutical R&D Expenditure, 2000-2021 (USD Million)
• Figure 29. Europe: Cytogenetics Market Snapshot
• Figure 30. Rest of Europe: Pharmaceutical R&D Expenditure, By Country, 2022 (USD Million)
• Figure 31. Asia-Pacific: Cytogenetics Market Snapshot
• Figure 32. Japan: Pharmaceutical R&D Expenditure, 1990-2022 (USD Million)
• Figure 33. Latin America: Cytogenetic Market Snapshot
• Figure 34. Middle East & Africa: Estimated Number of New Cancer Cases, By Country (2045)
• Figure 35. Middle East & Africa: Cytogenetics Market Snapshot
• Figure 36. Key Growth Strategies Adopted By Leading Players, 2021-2024
• Figure 37. Cytogenetics: Competitive Benchmarking, By Product
• Figure 38. Cytogenetics: Competitive Benchmarking, By Region
• Figure 39. Competitive Dashboard: Cytogenetics Market
• Figure 40. Cytogenetics Market Share Analysis By Key Players (2023)
• Figure 41. Thermo Fisher Scientific, Inc.: Financial Overview (2023)
• Figure 42. Abbott Laboratories: Financial Overview (2023)
• Figure 43. Agilent Technologies Inc.: Financial Overview (2023)
• Figure 44. Revvity, Inc: Financial Overview (2023)
• Figure 45. Bio-Rad Laboratories Inc.: Financial Overview (2023)
• Figure 46. Sysmex Corporation: Financial Overview (2024)
• Figure 47. Illumina Inc.: Financial Overview (2023)
• Figure 48. F. Hoffmann-La Roche Ltd.: Financial Overview (2023)
• Figure 49. Danaher Corporation: Financial Overview (2023)
• Figure 50. Quest Diagnostics Incorporated: Financial Overview (2023)